Get started
Author

Lucy Lee

Observed institution: PTC Therapeutics (United States)
ORCID: 0000-0001-6975-8459
Observed ORCID: 0000-0001-6975-8459
OpenAlex ID: A5011215708
Natural History and Real‐World Data in Rare Diseases: Applications, Limitations, and Future Perspectives
2022 · Jing Liu, Jeffrey S. Barrett, et al. · The Journal of Clinical Pharmacology · 153
PDF
Evaluation of vatiquinone drug-drug interaction potential in vitro and in a phase 1 clinical study with tolbutamide, a CYP2C9 substrate, and omeprazole, a CYP2C19 substrate, in healthy subjects
2022 · Katsuyuki Murase, Lucy Lee, et al. · European Journal of Clinical Pharmacology · 9
Clinical Drug‐Drug Interaction Between Vatiquinone, a 15‐Lipoxygenase Inhibitor, and Rosuvastatin, a Breast Cancer Resistance Protein Substrate
2022 · Lucy Lee, Katsuyuki Murase, et al. · Clinical Pharmacology in Drug Development · 7
Absorption, distribution, metabolism and excretion of 14 C-vatiquinone in rats, dogs, and human subjects
2023 · Jiyuan Ma, Lucy Lee, et al. · Xenobiotica · 6
PDF
Effect of Itraconazole, a CYP3A4 Inhibitor, and Rifampin, a CYP3A4 Inducer, on the Pharmacokinetics of Vatiquinone
2024 · Lucy Lee, Martin Thoolen, et al. · Clinical Pharmacology in Drug Development · 5
PDF
A clinical pharmacokinetic drug-drug interaction study between dextromethorphan and emvododstat, a potent anti-SARS-CoV-2 dihydroorotate dehydrogenase inhibitor
2023 · Terri L. Morton, Oscar L. Laskin, et al. · European Journal of Clinical Pharmacology · 3
PDF
Bridging the Gap With Clinical Pharmacology in Innovative Rare Disease Treatment Modalities: Targeting DNA to RNA to Protein
2022 · Lucy Lee, Rakesh Gollen, et al. · The Journal of Clinical Pharmacology · 3
Lack of Concentration‐QTc Relationship and Cardiac Risk With Vatiquinone Therapeutic and Supratherapeutic Doses
2024 · Lucy Lee, Stephen Flach, et al. · Clinical Pharmacology in Drug Development · 2
PDF
Characterizing Population Pharmacokinetics of Vatiquinone in Healthy Volunteers and Patients with Friedreich’s Ataxia
2025 · Yongjun Hu, Lan Gao, et al. · Pharmaceuticals · 1
PDF
A pharmacokinetic drug–drug interaction study between rosuvastatin and emvododstat, a potent anti‐SARS‐CoV ‐2 ( COVID ‐19) DHODH (dihydroorotate dehydrogenase) inhibitor
2023 · Terri L. Morton, Oscar L. Laskin, et al. · Pharmacology Research & Perspectives · 1
PDF
Enhanced Vatiquinone Bioavailability With Fatty Meals and Optimal Dosing Schedule
2025 · Lucy Lee, Katsuyuki Murase, et al. · Biopharmaceutics & Drug Disposition
PDF
Works count: 11
Citation count: 190
H-index: 5
I10-index: 1
Year
Topic
Type